Federal Circuit Holds Generic Drugs Manufactured in the U.S. from API Produced in India Qualify for Sale to U.S. under Trade Agreements Act (Acetris Decision)
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OK